🇺🇸 FDA
Patent

US 6491908

Selective elimination of T cells that recognize specific preselected targets

expired A61KA61K2035/122A61K2035/124

Quick answer

US patent 6491908 (Selective elimination of T cells that recognize specific preselected targets) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Dec 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Dec 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2035/122, A61K2035/124, A61K2239/38, A61K35/00